The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
The p53 tumor suppressor: A master regulator of diverse cellular processes and therapeutic target in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Erratum: PRIMA-1Met induces mitochondrial apoptosis through activation of caspase-2
Shen, J., Vakifahmetoglu, H., Stridh, H., Zhivotovsky, B., & Wiman, K. G. (2016) · Oncogene · doi:10.1038/onc.2016.210 · Cited by 54
Self-citationRetractedPRIMA-1MET induces mitochondrial apoptosis through activation of caspase-2
Shen, J., Vakifahmetoglu, H., Stridh, H., Zhivotovsky, B., & Wiman, K. G. (2008) · Oncogene · doi:10.1038/onc.2008.249 · Cited by 52
Self-citationRetractedBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
TIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions
Gorgoulis, V. G., Vassiliou, L.-V. F., Karakaidos, P., Zacharatos, P., Kotsinas, A., Liloglou, T., Venere, M., DiTullio, R. A., Kastrinakis, N. G., Levy, B., et al. (2005) · Nature · doi:10.1038/nature03485 · Cited by 2,009
Restoration of p53 function leads to tumour regression in vivo
Ventura, A., Kirsch, D. G., McLaughlin, M. E., Tuveson, D. A., Grimm, J., Lintault, L., Newman, J., Reczek, E. E., Weissleder, R., & Jacks, T. (2007) · Nature · doi:10.1038/nature05541 · Cited by 1,820
p53 Has a Direct Apoptogenic Role at the Mitochondria
Mihara, M., Erster, S., Zaika, A., Petrenko, O., Chittenden, T., Pancoska, P., & Moll, U. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00050-9 · Cited by 1,777
p53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459
DRAM, a p53-Induced Modulator of Autophagy, Is Critical for Apoptosis
Crighton, D., Wilkinson, S., O'Prey, J., Syed, N., Smith, P., Harrison, P. R., Gasco, M., Garrone, O., Crook, T., & Ryan, K. M. (2006) · Cell · doi:10.1016/j.cell.2006.05.034 · Cited by 1,380
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
Raver-Shapira, N., Marciano, E., Meiri, E., Spector, Y., Rosenfeld, N., Moskovits, N., Bentwich, Z., & Oren, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.017 · Cited by 1,352
When mutants gain new powers: News from the mutant p53 field
Brosh, R., & Rotter, V. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2693 · Cited by 1,132
The antioxidant function of the p53 tumor suppressor
Sablina, A. A., Budanov, A. V., Ilyinskaya, G. V., Agapova, L. S., Kravchenko, J. E., & Chumakov, P. M. (2005) · Nature Medicine · doi:10.1038/nm1320 · Cited by 1,121
Cytoplasmic functions of the tumour suppressor p53
Green, D. R., & Kroemer, G. (2009) · Nature · doi:10.1038/nature07986 · Cited by 1,106
Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
Bykov, V. J. N., Issaeva, N., Shilov, A., Hultcrantz, M., Pugacheva, E., Chumakov, P., Bergman, J., Wiman, K. G., & Selivanova, G. (2002) · Nature Medicine · doi:10.1038/nm0302-282 · Cited by 1,067
Self-citationKudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib
Kwak, E. L., Sordella, R., Bell, D. W., Godin-Heymann, N., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Driscoll, D. R., Fidias, P., Lynch, T. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502860102 · Cited by 952
Pharmacological Rescue of Mutant p53 Conformation and Function
Foster, B. A., Coffey, H. A., Morin, M. J., & Rastinejad, F. (1999) · Science · doi:10.1126/science.286.5449.2507 · Cited by 799
Mutant p53 drives invasion by promoting integrin recycling
Muller, P. A. J., Caswell, P. T., Doyle, B., Iwanicki, M. P., Tan, E. H., Karim, S., Lukashchuk, N., Gillespie, D. A., Ludwig, R. L., Gosselin, P., et al. (2009) · Cell · doi:10.1016/j.cell.2009.11.026 · Cited by 796
MicroRNA-125b is a novel negative regulator of p53
Le, M. T. N., Teh, C., Shyh-Chang, N., Xie, H., Zhou, B., Korzh, V., Lodish, H. F., & Lim, B. (2009) · Genes & Development · doi:10.1101/gad.1767609 · Cited by 655
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Modeling the Therapeutic Efficacy of p53 Restoration in Tumors
Martins, C. P., Brown-Swigart, L., & Evan, G. I. (2006) · Cell · doi:10.1016/j.cell.2006.12.007 · Cited by 600
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
Self-citationDelayed ageing through damage protection by the Arf/p53 pathway
Matheu, A., Maraver, A., Klatt, P., Flores, I., Garcia-Cao, I., Borras, C., Flores, J. M., Viña, J., Blasco, M. A., & Serrano, M. (2007) · Nature · doi:10.1038/nature05949 · Cited by 466
Targeted rescue of a destabilized mutant of p53 by an in silico screened drug
Boeckler, F. M., Joerger, A. C., Jaggi, G., Rutherford, T. J., Veprintsev, D. B., & Fersht, A. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805326105 · Cited by 387
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm
Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 368
Self-citationThe promises and perils of p53
Krizhanovsky, V., & Lowe, S. W. (2009) · Nature · doi:10.1038/4601085a · Cited by 274
PRIMA-1MET synergizes with cisplatin to induce tumor cell apoptosis
Bykov, V. J. N., Zache, N., Stridh, H., Westman, J., Bergman, J., Selivanova, G., & Wiman, K. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208419 · Cited by 252
Self-citationWrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage
Mahmoudi, S., Henriksson, S., Corcoran, M., Méndez-Vidal, C., Wiman, K. G., & Farnebo, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.11.027 · Cited by 250
Self-citationWrap53, a Natural p53 Antisense Transcript Required for p53 Induction upon DNA Damage
Mahmoudi, S., Henriksson, S., Corcoran, M., Méndez-Vidal, C., Wiman, K. G., & Farnebo, M. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.01.028 · Cited by 248
Self-citationp53 and its isoforms in cancer
Bourdon, J.-C. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603886 · Cited by 245
Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells
Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M., Levrero, M., Strano, S., Gorgoulis, V. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2425 · Cited by 199
Bykov, V. J. N. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.2011 · Cited by 172
Self-citationCharacterization of the p53-rescue drug CP-31398 in vitro and in living cells
Rippin, T. M., Bykov, V. J. N., Freund, S. M. V., Selivanova, G., Wiman, K. G., & Fersht, A. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205362 · Cited by 151
Self-citationStrategies for therapeutic targeting of the p53 pathway in cancer
Wiman, K. G. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401921 · Cited by 136
Self-citationMicroRNA 125a and its regulation of the p53 tumor suppressor gene
Zhang, Y., Gao, J., Tang, X., Tucker, L. D., Quesenberry, P. J., Rigoutsos, I., & Ramratnam, B. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.10.002 · Cited by 114
Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis
Lambert, J. M. R., Moshfegh, A., Hainaut, P. L., Wiman, K. G., & Bykov, V. J. N. (2009) · Oncogene · doi:10.1038/onc.2009.425 · Cited by 112
Self-citationBauer, J. H., Poon, P. C., Glatt-Deeley, H., Abrams, J. M., & Helfand, S. L. (2005) · Current Biology · doi:10.1016/j.cub.2005.10.051 · Cited by 100
The p53 target Wig-1 regulates p53 mRNA stability through an AU-rich element
Vilborg, A., Glahder, J. A., Wilhelm, M., Bersani, C., Corcoran, M., Mahmoudi, S., Rosenstierne, M. W., Grandér, D., Farnebo, M., Norrild, B., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900862106 · Cited by 94
Self-citationLiang, Y., Besch-Williford, C. L., Brekken, R. A., & Hyder, S. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1103 · Cited by 88
PRIMA-1 inhibits growth of breast cancer cells by re-activating mutant p53 protein
Hyder (2009) · International Journal of Oncology · doi:10.3892/ijo_00000416 · Cited by 74
Hainaut, P. L., & Wiman, K. G. (2005) · Springer eBooks · doi:10.1007/978-1-4020-2922-6 · Cited by 73
Self-citationPRIMA-1MET inhibits growth of mouse tumors carrying mutant p53.
(2008) · PubMed Central · doi:10.3233/clo-2008-0440 · Cited by 68
Reduced expression of the Caenorhabditis elegans p53 ortholog cep-1 results in increased longevity
Arum, O., & Johnson, T. E. (2007) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/62.9.951 · Cited by 64
PRIMA‐1 induces apoptosis in acute myeloid leukaemia cells with p53 gene deletion
Nahi, H., Merup, M., Lehmann, S., Bengtzén, S., Möllgård, L., Selivanova, G., Wiman, K. G., & Paul, C. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05851.x · Cited by 62
Self-citationWrap53, a novel regulator of p53
Farnebo, M. (2009) · Cell Cycle · doi:10.4161/cc.8.15.9223 · Cited by 51
Self-citationEffects of PRIMA‐1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion
Nahi, H., Lehmann, S., Mollgard, L., Bengtzen, S., Selivanova, G., Wiman, K. G., Paul, C., & Merup, M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.05210.x · Cited by 50
Self-citationMutant p53 rescue and modulation of p53 redox state
Bykov, V. J. N., Lambert, J. M. R., Hainaut, P. L., & Wiman, K. G. (2009) · Cell Cycle · doi:10.4161/cc.8.16.9382 · Cited by 46
Self-citationPosttranscriptional Regulation of p53 and its Targets by RNABinding Proteins
Zhang, J., & Chen, X. (2008) · Current Molecular Medicine · doi:10.2174/156652408786733748 · Cited by 43
Shi, H., Lambert, J. M. R., Hautefeuille, A. H., Bykov, V. J. N., Wiman, K. G., Hainaut, P. L., & de Fromentel, C. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm266 · Cited by 35
Self-citationSuppression of Familial Adenomatous Polyposis by CP-31398, a TP53 Modulator, in APCmin/+ Mice
Rao, C. V., Swamy, M. V., Patlolla, J. M. R., & Kopelovich, L. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1610 · Cited by 34
Duan, W., Gao, L., Wu, X., Wang, L., Nana-Sinkam, S. P., Otterson, G. A., & Villalona-Calero, M. A. (2009) · International Journal of Cancer · doi:10.1002/ijc.25049 · Cited by 28
The rapid destabilization of p53 mRNA in immortal chicken embryo fibroblast cells
Kim, H., You, S., Foster, L. K., Farris, J., & Foster, D. N. (2001) · Oncogene · doi:10.1038/sj.onc.1204664 · Cited by 28
Cited by
The functional role of long non-coding RNA in human carcinomas
Gibb, E. A., Brown, C. J., & Lam, W. L. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-38 · Cited by 1,619
The Role of Resveratrol in Cancer Therapy
Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122589 · Cited by 800
Ahamed, M., Akhtar, J., Kumar, Khan, M., Ahmad, & Alrokayan (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s29129 · Cited by 701
p53 mutations in colorectal cancer- molecular pathogenesis and pharmacological reactivation
Li, X.-L. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i1.84 · Cited by 367
Oxidative stress mediated apoptosis induced by nickel ferrite nanoparticles in cultured A549 cells
Ahamed, M., Akhtar, M. J., Siddiqui, M. A., Ahmad, J., Musarrat, J., Al-Khedhairy, A. A., AlSalhi, M. S., & Alrokayan, S. A. (2011) · Toxicology · doi:10.1016/j.tox.2011.02.010 · Cited by 319
Metadata
- Authors
- Farnebo, M., Bykov, V. J. N., & Wiman, K. G.
- Venue
- Biochemical and Biophysical Research Communications
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 396
- Issue
- 1
- Pages
- 85-89
- ISSN
- 0006-291X (ISSN-L)
- OpenAlex
- W2050540135
- Cited by
- 268
- References
- 55
- FWCI
- 12.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.